Nephrotoxicants Induce Endothelin Release and Signaling in Renal Proximal Tubules: Effect on Drug Efflux
- 1Department of Pharmacology and Toxicology, University Medical Centre Nijmegen, Nijmegen, The Netherlands (S.A.T., R.M., F.G.M.R.);2Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina (D.S.M.); and 3Mount Desert Island Biological Laboratory, Salisbury Cove, Maine (S.A.T., D.S.M.)
Abstract
We previously used killifish proximal tubules, fluorescent substrates, and confocal microscopy to demonstrate that transport mediated by the multidrug resistance protein (Mrp2) and by P-glycoprotein was reduced by nanomolar concentrations of endothelin-1 (ET), acting through a basolateral B-type ET receptor and protein kinase C (PKC). Here we show that representatives of two classes of nephrotoxicants decrease transport by activating the endothelin-PKC signaling pathway. Exposing tubules to radiocontrast agents (iohexol, diatrizoate) or aminoglycoside antibiotics (gentamicin, amikacin) reduced Mrp2-mediated fluorescein methotrexate (FL-MTX) transport from cell to tubular lumen. Pretreating the tubules with an ETB-receptor antagonist or with PKC-selective inhibitors abolished these effects. The nephrotoxicants activated signaling by inducing release of ET from the tubules, because adding of an antibody against ET to the medium abolished the effects. Elevating medium Ca2+ also reduced FL-MTX transport; this reduction was abolished when tubules were pretreated with an ET antibody, an ETB-receptor antagonist, PKC-selective inhibitors, or the Ca2+ channel blocker, nifedipine. None of these drugs by themselves affected FL-MTX transport. Importantly, nifedipine also blocked the ETB-receptor/PKC-dependent reduction in FL-MTX transport caused by gentamicin and diatrizoate. These results for two classes of structurally unrelated nephrotoxicants suggest that Ca2+-dependent ET release and subsequent action through an autocrine mechanism may be an early response to tubular injury.
Footnotes
-
Send reprint requests to: Rosalinde Masereeuw, Ph.D., Dept. of Pharmacology/Toxicology 233, University Medical Center Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. E-mail:r.masereeuw{at}farm.kun.nl.
-
This work was supported by a travel grant from the Netherlands Organization for Scientific Research (S.A.T.).
-
This work was presented in part at Experimental Biology '00 and published as a preliminary abstract: Terlouw SA, Masereeuw R, Russel FGM and Miller DS (2000) Bull Mt Desert Island Biol Lab39:84–85.
- Abbreviations:
- ET
- endothelin
- Mrp2
- multidrug resistance protein 2
- PKC
- protein kinase C
- FL
- fluorescein
- MTX
- methotrexate
- PMA
- phorbol 12-myristate 13-acetate
- BIM
- bis-indolylmaleimide I
-
- Received September 14, 2000.
- Accepted February 13, 2001.
- The American Society for Pharmacology and Experimental Therapeutics



